| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.0B | $14.6B | $12.6B | $11.1B | $9.9B | $8.8B | $9.2B | $8.1B |
| Cost of Revenue | $13.7B | $11.8B | $10.5B | $9.5B | $8.4B | $7.4B | $7.8B | $6.9B |
| Gross Profit | $3.3B | $2.8B | $2.1B | $1.6B | $1.5B | $0.4B | $0.4B | $0.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.7B | $1.4B | $1.2B | $1.0B | $1.0B | $0.9B | $0.9B | $0.8B |
| Operating Income | $1.7B | $1.3B | $0.9B | $0.6B | $0.5B | $0.3B | $0.5B | $0.4B |
| Net Income | $1.3B | $1.0B | $0.6B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $28.30 | $21.61 | $13.37 | $8.13 | $7.09 | $2.41 | $1.54 | $1.37 |
| EPS (Diluted) | $28.19 | $21.52 | $13.31 | $8.10 | $7.06 | $2.40 | $1.54 | $1.36 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.3B | $7.7B | $6.6B | $5.5B | $5.4B | $5.1B | $4.8B | $4.1B |
| Current Assets | $5.9B | $5.4B | $4.4B | $3.5B | $3.4B | $3.1B | $2.7B | $2.4B |
| Cash & Equivalents | $1.1B | $1.3B | $0.8B | $0.5B | $0.8B | $0.9B | $0.4B | $0.4B |
| Total Liabilities | $5.6B | $4.8B | $4.1B | $3.6B | $3.2B | $3.0B | $2.8B | $2.3B |
| Current Liabilities | $4.9B | $4.2B | $3.5B | $2.8B | $2.4B | $2.2B | $1.9B | $1.7B |
| Stockholders' Equity | $3.7B | $2.9B | $2.5B | $2.0B | $2.3B | $2.1B | $2.1B | $1.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.4B | $0.9B | $0.5B | $0.3B | $0.8B | $0.4B | $0.3B |
| Investing Cash Flow | $-0.9B | $-0.3B | $-0.2B | $-0.1B | $-0.2B | $-0.1B | $-0.3B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.7B | $-0.6B | $-0.4B | $-0.7B | $-0.2B | $-0.2B | $-0.0B | $-0.3B |